Evaluating Crosslinked Hyaluronate Canalicular Gel for the Treatment of DED in Patients Undergoing Cataract Surgery

Trial statusRecruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age22+
SponsorVance Thompson Vision

About this trial

To review how patients report using a hyaluronate crosslinked canalicular gel placed before cataract surgery

Eligibility criteria

Qualifiers

Be willing and able to understand and sign the informed consent form (ICF)

Men or non-pregnant women age 22 or older

Clear intraocular media other than cataract

Diagnosis of dry eye disease (OSDI score ≥ 13)

Disqualifiers

History of punctal cautery

Lacrimal anatomy (e.g., nasolacrimal duct obstruction) that per investigator suggests that the patient would not be a good candidate for lacrimal occlusion or patients for whom lacrimal occlusion would increase risk

Trial design

Treatments tested in this trial

  • Cross-Linked Hyaluronate Gel Prefilled Syringe 30 MG/3ML

Treatment groups

60 Participants
are divided into 1 treatment group

Sponsors and collaborators